Clinical Trial Update: QYJD Compound Preparation Promotes Rapid Postoperative Recovery in Early-stage NSCLC Patients by Regulating Tissue Microecology: a Prospective, Randomized Controlled, Open-label, Phase I Clinical Study With Predefined Future Exploration [Phase 1]

View source ↗

Summary

A Phase 1 randomized, open-label trial evaluating QYJD Compound Preparation for improving postoperative recovery in early-stage non-small cell lung cancer, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• QYJD Compound Preparation

Snippet

Sponsor: Fuzhou General Hospital | Conditions: NSCLC | Phase 1 | Status: COMPLETED